Bank of America’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-13,943
| Closed | -$73K | – | 7613 |
|
|
2016
Q4 | $73K | Buy |
13,943
+484
| +4% | +$2.27K | ﹤0.01% | 5766 |
|
|
2016
Q3 | $63K | Hold |
13,459
| – | – | ﹤0.01% | 5650 |
|
|
2016
Q2 | $53K | Buy |
13,459
+3,515
| +35% | +$13.1K | ﹤0.01% | 5816 |
|
|
2016
Q1 | $31K | Buy |
9,944
+8,889
| +843% | +$29.8K | ﹤0.01% | 5969 |
|
|
2015
Q4 | $5K | Sell |
1,055
-50
| -5% | -$237 | ﹤0.01% | 6918 |
|
|
2015
Q3 | $5K | Sell |
1,105
-414
| -27% | -$2.67K | ﹤0.01% | 6800 |
|
|
2015
Q2 | $11K | Buy |
1,519
+1,449
| +2,070% | +$10.9K | ﹤0.01% | 6574 |
|
|
2015
Q1 | $1K | Sell |
70
-130
| -65% | -$1.11K | ﹤0.01% | 6983 |
|
|
2014
Q4 | $2K | Sell |
200
-2,106
| -91% | -$18.3K | ﹤0.01% | 7532 |
|
|
2014
Q3 | $19K | Buy |
2,306
+1,506
| +188% | +$13.9K | ﹤0.01% | 7091 |
|
|
2014
Q2 | $9K | Buy |
+800
| New | +$8.21K | ﹤0.01% | 7522 |
|
|
2014
Q1 | – | Sell |
-52
| Closed | -$1K | – | 8691 |
|
|
2013
Q4 | $1K | Sell |
52
-6,646
| -99% | -$77.2K | ﹤0.01% | 7835 |
|
|
2013
Q3 | $83K | Buy |
6,698
+4,033
| +151% | +$55.8K | ﹤0.01% | 6114 |
|
|
2013
Q2 | $36K | Buy |
+2,665
| New | +$34.3K | ﹤0.01% | 6750 |
|
Other funds holding DSCI
Bank of America's DSCI Position: Q1 2017 in Review
Bank of America sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 13,943 shares — an estimated $73K sold.
Bank of America first reported a position in DSCI in Q2 2013 and held it in 14 quarters. The position peaked at $83K in Q3 2013. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- Bank of America reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
- Bank of America sold 13,943 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $73K.
- Bank of America first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 14 quarters.
- Bank of America's Derma Sciences, Inc. Common Stock (DE) position peaked at $83K in Q3 2013.
- 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.
Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.